NAV

Terpineol

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Summary

Terpineol is an ingredient in products that are adjunct in the treatment of upper respiratory tract congestion.

Generic Name
Terpineol
DrugBank Accession Number
DB15956
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
3D
Similar Structures
Weight
Average: 154.253
Monoisotopic: 154.1357652
Chemical Formula
C10H18O
Synonyms
Not Available
External IDs
  • 232-268-1
Poor quality drug data slowing you down?
Unlock 38% more drug discovery time and eliminate decision-making doubts with this one-stop guide to quality drug data.
Download eBook
Poor quality drug data slowing you down?
Download eBook

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Associated Conditions
Indication TypeIndicationCombined Product DetailsApproval LevelAge GroupPatient CharacteristicsDose Form
Used in combination to treatCommon coldCombination Product in combination with: Eucalyptol (DB03852)••• •••
Used in combination to treatLaryngitisCombination Product in combination with: Eucalyptol (DB03852)••• •••
Used in combination to treatLaryngitisCombination Product in combination with: Eucalyptol (DB03852)••• •••
Used in combination to treatPharyngitisCombination Product in combination with: Eucalyptol (DB03852)••• •••
Used in combination to treatRhinitisCombination Product in combination with: Eucalyptol (DB03852)••• •••
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now

Categories

Drug Categories
Not Available
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
21334LVV8W
CAS number
8000-41-7
InChI Key
WUOACPNHFRMFPN-UHFFFAOYSA-N
InChI
InChI=1S/C10H18O/c1-8-4-6-9(7-5-8)10(2,3)11/h4,9,11H,5-7H2,1-3H3
IUPAC Name
2-(4-methylcyclohex-3-en-1-yl)propan-2-ol
SMILES
CC1=CCC(CC1)C(C)(C)O

References

General References
  1. AIFA: Calyptol (Eucalyptol, Terpineol) Inhalant [Link]
KEGG Compound
C16772
ChemSpider
13850142
RxNav
1368180
ChEBI
22469
ChEMBL
CHEMBL449810
Wikipedia
Terpineol

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility1.56 mg/mLALOGPS
logP3.17ALOGPS
logP2.17Chemaxon
logS-2ALOGPS
pKa (Strongest Acidic)19.4Chemaxon
pKa (Strongest Basic)-0.87Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count1Chemaxon
Hydrogen Donor Count1Chemaxon
Polar Surface Area20.23 Å2Chemaxon
Rotatable Bond Count1Chemaxon
Refractivity48.46 m3·mol-1Chemaxon
Polarizability19.07 Å3Chemaxon
Number of Rings1Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleYesChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-001a-9700000000-8943e6918de65ed02198
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-0udr-0900000000-67bc7efa9a7ff43f7f38
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-0udi-0900000000-243c8fa31e582687b2c7
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-0002-9100000000-e7ffa1a4f2aa0415965b
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-0uxu-9400000000-3a9e563e86e757a0157c
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-0007-9000000000-f445101c33e059dc6215
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-137.18172
predicted
DeepCCS 1.0 (2019)
[M+H]+139.91737
predicted
DeepCCS 1.0 (2019)
[M+Na]+148.86642
predicted
DeepCCS 1.0 (2019)

Drug created at November 26, 2020 21:29 / Updated at May 07, 2021 21:09